Virginia Carnahan

Virginia Carnahan has been a driving force in the biotechnology industry for over two decades. Virginia currently serves as the Chair of the Board of Trustees at Beth Israel Deaconess Hospital-Needham, one of the leading healthcare providers in Massachusetts.

Virginia's career in the biotech industry began at Vertex Pharmaceuticals, where they served as Vice President and Chief of Staff to the CEO. In this role, they were responsible for facilitating the development and execution of corporate-level plans, and provided thought leadership and business support to the CEO. Virginia also played a key role in the development of new corporate research strategy and long-range target disease opportunities as a member of the Steering Committee.

In 2015, Virginia was recruited by the Massachusetts state government to help launch the Massachusetts Digital Health Care Initiative, a statewide effort to improve healthcare delivery through digital technology. As a private sector partner in this initiative, Virginia helped to connect city and state executive leaders with leading healthcare providers and technology companies to make this ambitious project a reality.

Virginia's work has had a profound impact on the healthcare landscape in Massachusetts. Through their leadership and vision, they have helped to improve access to quality care for all residents of the Commonwealth.

Virginia Carnahan has a MBA in Finance and Marketing from Duke University - The Fuqua School of Business and a BBA in marketing from Saint Mary's College.